Notable Labs Inc. (NTBL): Balans kapitallashuviga qarzlar

Predictive dasturiy ta'minotning tijoratlashtirilishi vaqt va tashqi moliyalashtirishni talab qiladi, bu esa Notable Labs, Ltd. (NTBL) kompaniyasining joriy bozor dinamikasini belgilaydi. Balans kapitalizatsiyasidagi qarz moliyalashtirish ulushi majburiyatlar tuzilmasining barqarorligini ko'rsatadi, bunda ushbu ko'rsatkich 0.00 miqdorida baholangan. Biznesning muvaffaqiyati noyob AI qon tahlili patentlariga tayanadi, garchi ishlanmalar algoritmlarning aniqligi va klinikalarga bo'lgan sheriklikka bog'liq bo'lsa-da.

Notable Labs, Ltd. (NTBL) - Balans qiymatiga qarzlar 21.02.2024dan 02.11.2024gacha

Notable Labs Ltd (NTBL) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Notable Labs, Ltd.|NTBL - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Notable Labs Corp|NTBL - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Notable Labs|NTBL - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati notablelabs.com|NTBL - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Notable Labs, Ltd.|NTBL - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Notable Labs Inc.|NTBL - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati Notable Labs Corp|NTBL - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Notable Labs
Kompaniyaning barcha koʻrsatkichlari tahlili:Notable Labs, Ltd. NTBL

Notable Labs, Ltd. (NTBL) moliyaviy barqarorligi qarz mablag‘lari va o‘z kapitali o‘rtasidagi muvozanat bilan belgilanadi. Balansdagi kapital tuzilmasiga nisbatan qarz majburiyatlarining dinamikasi biznesning kreditorlarga bo‘lgan bog‘liqlik darajasini aks ettiradi. Ushbu ko‘rsatkich umumiy qarzning umumiy aktivlar qiymatidan majburiyatlar ayirib tashlangan miqdorga nisbati sifatida hisoblanadi. Aniqlik onkologiyasining kengayish bosqichidagi kompaniya uchun me’yordagi leveraj platformaning masshtabini kengaytirishni rag‘batlantiradi. Ushbu nisbatning kamayishi biznesning ichki qiymati o‘sayotganini tasdiqlaydi.

Notable Labs, Ltd. kimlar bilan raqobatlashadi

ONC - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD: Balans kapitallashuviga qarzlar|AAPG - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CGON|URGN (UroGen Pharma Corp) - Balans qiymatiga qarzlar|BCAX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati personalis.com (PSNL)|Erasca (ERAS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Delcath Systems Inc (DCTH)|YmAbs - Balans kapitallashuviga qarzlar|AURA - Qarzning balans qiymatiga nisbati|Candel - Qarzning balans qiymatiga nisbati|ARAY: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati sellaslifesciences.com SLS|Actuate Therapeutics Inc. (ACTU) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CTOR (Citius Oncology, Inc)|Balans qiymatiga qarzlar HURA|Qarzning balans kapitallashuviga nisbati Protara Therapeutics TARA|Qarzning balans qiymatiga nisbati FATE (fatetherapeutics.com)|WHWK: Qarzning balans kapitallashuviga nisbati|TCRX - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Champions Oncology Corp CSBR|XBIT - Qarzning balans kapitaliga nisbati|CVM: Balans kapitallashuviga qarzlar|ostherapies.com (OSTX) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Radiopharm Theranostics Limited|Qarzning balans kapitallashuviga nisbati ARTV|Qarzning balans kapitallashuviga nisbati Adlai Nortye Ltd. (ANL)|Qarzning balans kapitallashuviga nisbati Veru Corporation (VERU)|TPST: Balans kapitallashuviga qarzlar|XLO - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Enochian BioSciences (RENB)|MURA: Qarzning sof aktivlarga nisbati|kairospharma.com (KAPA) - Qarzning balans kapitallashuviga nisbati|OnKure Therapeutics (OKUR) - Qarzning balans kapitallashuviga nisbati|GDTC (CytoMed Therapeutics Ltd) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Curis Corp|Balans kapitallashuviga qarzlar Apollomics, Inc. (APLM)|Qarzning balans kapitallashuviga nisbati THAR (Tharimmune Inc)|Qarzning balans kapitallashuviga nisbati ADVB|GNPX - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Calidi Bio (CLDI)|SBFM: Qarzning sof aktivlarga nisbati|xeneticbio.com (XBIO) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Salarius Pharmaceuticals Inc|Purple Biotech Corp (PPBT) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati AON|Balans kapitallashuviga qarzlar BeiGene, Ltd. BGNE|Qarzning balans qiymatiga nisbati checkpointtx.com CKPT|Qarzning balans qiymatiga nisbati ELEV|iCAD Inc. - Sof aktivlarga qarzlar|Ikena (IKNA) - Qarzning balans kapitallashuviga nisbati|Viracta Therapeutics (VIRX) - Qarzning balans qiymatiga nisbati|MOR - Qarzning balans qiymatiga nisbati|nayabiosciences.com (NAYA) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Ascentage Pharma